Uganda receives monoclonal antibody treatment for Ebola
Uganda was declared Ebola-free on July 28, 2026, following the conclusion of the outbreak response.
Uganda has received a donation of MBP134 monoclonal antibody treatment for Ebola virus as the country strengthens its preparedness against future outbreaks.
The donation was received by Dr Charles Ayume, Minister of State for Health in charge of Primary Health Care, at the National Medical Stores (NMS) offices in Kajjansi.
The treatment, which was donated with support from the US government and developed by biopharmaceutical researchers, is designed to act faster than the body’s natural immune response by neutralising the Ebola virus.
According to health authorities, the availability of the monoclonal antibody treatment will strengthen Uganda’s capacity to respond to potential Ebola infections and reduce the risk of severe disease and deaths.
Uganda was declared Ebola-free on July 28, 2026, following the conclusion of the outbreak response.
The latest donation comes as Uganda continues to maintain surveillance and preparedness measures aimed at preventing and rapidly responding to any new Ebola cases.
Health officials have continued to emphasise the importance of early detection, rapid response and access to effective treatment in controlling viral disease outbreaks.
